Chargement en cours...
Ineffective Subtilisin/Kexin Type 9 (PCSK9) Inhibitors Monotherapy in Dyslipidemia with Low-Density Lipoprotein Cholesterol (LDL-C) Receptor Abnormalities: A Report of 2 Cases
Case series Patients: Male, 44-year-old • Female, 71-year-old Final Diagnosis: Resistance to PCSK9I overcomed by adding statin Symptoms: Dyslipidemia Medication: — Clinical Procedure: — Specialty: Cardiology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Real-life data on the effic...
Enregistré dans:
| Publié dans: | Am J Case Rep |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
International Scientific Literature, Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7520129/ https://ncbi.nlm.nih.gov/pubmed/32929056 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/AJCR.923722 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|